MGTX - MeiraGTx Holdings PLC logo

MeiraGTx Holdings PLC

MGTX

MeiraGTx Holdings plc focuses on developing genetic therapies for serious conditions, including ocular and neurodegenerative diseases. Its pipeline features treatments for retinal dystrophies, Parkinson's disease, and xerostomia, alongside riboswitch technology.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$801today

Score Overview

1 Year
Score
Net Growth-5.54%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-2.01%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.8
Net Growth-51.50%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth111.55%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-45.46%
Net Trend38%
Net Income Consistency
Rev Growthโ€”
Rev Trend63%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where MeiraGTx Holdings PLC has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 1 year of fundamentals. MGTX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 10.66โ€”
1 Year2025-10-01
$ 8.2728.90%
5 Years2021-10-01
$ 13.31-19.91%
All Time2018-06-08
$ 15.00-28.93%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 79M-$ 120M$ 71M
2025$ 81M-$ 114M$ 65M
2024$ 33M-$ 147M$ 103M
2023$ 14M-$ 84M$ 129M
2022$ 15M-$ 129M$ 115M
2021$ 37M-$ 79M$ 137M
2020$ 15M-$ 57M$ 209M
2019$ 13M-$ 54M$ 227M
IPO2018$ 0.00-$ 82M$ 68M
MGTX - MeiraGTx Holdings PLC logo

MeiraGTx Holdings PLC fundamental performance

Between 2020 and 2025, revenue grew from $ 15M to $ 81M and net income went from -$ 57M to -$ 114M. Revenue increased in 2 of those 5 years; net income in 2.

MeiraGTx Holdings PLC currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Explore MGTX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies